MedTrace Logo

Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns

NCT02689700 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2017-03-07

No results posted yet for this study

Summary

The aim of the study is to determine the total concentration of HCMV- and VZV-specific IgG-antibodies and the total concentration of neutralizing antibodies against HCMV in neonatal bloodstream depending on gestational age at birth.

Conditions

  • Materno-fetal Transfer of Anti-HCMV-IgG
  • Materno-fetal Transfer of Anti-VZV-IgG

Interventions

OTHER

Blood samples

Taking blood form the umbilical cord (fetal circulation) and from the vein of the corresponding mother.

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Eligibility

Min Age
1 Minute
Max Age
10 Minutes
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-12-31
Completion
2018-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02689700 on ClinicalTrials.gov